Nabriva Therapeutics Plc
Nabriva Therapeutics Plc's email is office@nabriva.com
and
Nabriva Therapeutics Plc's phone number is (430) 174-0930
.
Nabriva Therapeutics is a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections. Nabriva Therapeutics received U.S. Food and Drug Administration approval for XENLETA® (lefamulin injection, lefamulin tablets), the first systemic pleuromutilin antibiotic for community-acquired bacterial pneumonia (CABP). Nabriva Therapeutics is also developing CONTEPO™ (fosfomycin) for injection, a potential first-in-class epoxide antibiotic for complicated urinary tract infections (cUTI), including acute ...
read more
Nabriva Therapeutics is a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections. Nabriva Therapeutics received U.S. Food and Drug Administration approval for XENLETA® (lefamulin injection, lefamulin tablets), the first systemic pleuromutilin antibiotic for community-acquired bacterial pneumonia (CABP). Nabriva Therapeutics is also developing CONTEPO™ (fosfomycin) for injection, a potential first-in-class epoxide antibiotic for complicated urinary tract infections (cUTI), including acute pyelonephritis. Nabriva entered into an exclusive agreement with subsidiaries of Merck & Co. Inc., Kenilworth, N.J., USA to market, sell and distribute SIVEXTRO® (tedizolid phosphate) in the United States and certain of its territories.
show less
Website | nabriva.com | |
Industry | Biotechnology | |
Location | King Of Prussia, Pennsylvania, United States | |
Employees | 85 | |
Founded | 2006 |
HQ | Leberstrasse 20 | |
Phone | (430) 174-0930 | |
office@nabriva.com | ||
Funding | 325,869,173 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | nabriva.com | |
Industry | Biotechnology | |
Location | King Of Prussia, Pennsylvania, United States | |
Employees | 85 | |
Founded | 2006 | |
linkedin.com/company/nabriva-therapeutics | ||
HQ | Leberstrasse 20 | |
Phone | (430) 174-0930 | |
office@nabriva.com | ||
Funding | 325,869,173 USD |
Email Patterns for Nabriva Therapeutics Plc
Top Competitors for Nabriva Therapeutics Plc
Nabriva Therapeutics Plc Questions
Where are Nabriva Therapeutics Plc's headquarters?
Nabriva Therapeutics Plc's headquarters are in Leberstrasse 20
What is Nabriva Therapeutics Plc's phone number?
Nabriva Therapeutics Plc's phone number is (430) 174-0930
What is Nabriva Therapeutics Plc's official website?
Nabriva Therapeutics Plc's website is nabriva.com
How many employees are working in Nabriva Therapeutics Plc right now?
Nabriva Therapeutics Plc has
85 employees.
View the Email and Phone Numbers for all 85 working at Nabriva Therapeutics Plc.
What is Nabriva Therapeutics Plc's industry?
Nabriva Therapeutics Plc's industry is
Biotechnology
Who are Nabriva Therapeutics Plc's top competitors?
Nabriva Therapeutics Plc's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Nabriva Therapeutics Plc's email address?
Nabriva Therapeutics Plc's email address is office@nabriva.com
What are Nabriva Therapeutics Plc's categories?
Nabriva Therapeutics Plc's categories are Biotechnology, Health Care, Medical
What is Nabriva Therapeutics Plc's location?
Nabriva Therapeutics Plc's location is
King Of Prussia, Pennsylvania, United States
When was Nabriva Therapeutics Plc's founded?
Nabriva Therapeutics Plc's founding year is 2006
What is Nabriva Therapeutics Plc's funding?
Nabriva Therapeutics Plc's funding is 325,869,173 USD
What is Nabriva Therapeutics Plc's current status?
Nabriva Therapeutics Plc's current status is ipo
Top Nabriva Therapeutics Plc Employees
Senior Accountant
ktucker967@gmail.com
+1412-644-7890
President And Chief Operating Officer
sgelone@viropharma.com
+1610-816-6640
Director Of It System Integrations And Business Systems
vincenza.krikorian@viropharma.com
+1610-476-1590
Manager, Sales And Market Access
cavanagh.miranda@gmail.com
+1201-406-1144
General Counsel And Secretary
r.crotty@vernalis.com
+1908-864-5621
Marketing Services Manager
vik2004@aol.com
+1215-443-9406
Vice President Of Quality At Nabriva Therapeutics
acortes@comcast.net
+1858-875-8600